These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34893381)

  • 1. First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
    Peacock WF; Slatkin NE; Israel RJ; Stambler N
    J Emerg Med; 2022 Feb; 62(2):231-239. PubMed ID: 34893381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
    Brenner DM; Slatkin NE; Stambler N; Israel RJ; Coluzzi PH
    Support Care Cancer; 2021 Sep; 29(9):5209-5218. PubMed ID: 33629189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
    Liao SS; Slatkin NE; Stambler N
    Drugs Aging; 2021 Jun; 38(6):503-511. PubMed ID: 33788162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose.
    Chamberlain BH; Rhiner M; Slatkin NE; Stambler N; Israel RJ
    J Pain Res; 2023; 16():2595-2607. PubMed ID: 37533563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.
    Bull J; Wellman CV; Israel RJ; Barrett AC; Paterson C; Forbes WP
    J Palliat Med; 2015 Jul; 18(7):593-600. PubMed ID: 25973526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Habeeb EA; Tran LK; Goodberlet MZ; Lupi KE; DeGrado JR; Dube KM
    Ann Pharmacother; 2023 Jul; 57(7):762-768. PubMed ID: 36314271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.
    Janku F; Johnson LK; Karp DD; Atkins JT; Singleton PA; Moss J
    Ann Oncol; 2016 Nov; 27(11):2032-2038. PubMed ID: 27573565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Tobben D; Carpenter S; Kolar R; Merritt T; Young T; Hauser P; Collier T
    Ann Pharmacother; 2024 Jul; 58(7):678-684. PubMed ID: 37881915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
    Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
    Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
    Farchadi D; Slatkin NE; Stambler N; Israel RJ; Matus M
    Curr Ther Res Clin Exp; 2023; 98():100694. PubMed ID: 36875317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
    Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
    J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR; Klok RM; Iyer S; McDade C
    Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies.
    Chamberlain BH; Rhiner M; Slatkin NE; Stambler N; Israel RJ
    J Pain Res; 2021; 14():2687-2697. PubMed ID: 34512008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.